Showing results (61-70 of 193) with videos related to

Sort By:
Pageof 20
BMC Neurology|August 27, 2009
Quality of life as an outcome in Alzheimer's disease and other dementias--obstacles and goalsMatthias W Riepe, Thomas Mittendorf, Hans Förstl, et al.
Alzheimer Disease and Associated Disorders|October 12, 2011
CORDIAL: cognitive rehabilitation and cognitive-behavioral treatment for early dementia in Alzheimer disease: a multicenter, randomized, controlled trialAlexander Kurz, Angelika Thöne-Otto, Barbara Cramer, et al.
Psychiatry Research|August 21, 2003
Brain metabolism in Alzheimer disease and vascular dementia assessed by in vivo proton magnetic resonance spectroscopySebastian Herminghaus, Lutz Frölich, Corrina Gorriz, et al.
In Vivo (Athens, Greece)|January 6, 2021
Evaluation of Sodium (23Na) MR-imaging as a Biomarker and Predictor for Neurodegenerative Changes in Patients With Alzheimer's DiseaseSherif A Mohamed, Katrin Herrmann, Anne Adlung, et al.
Alzheimer'S Research & Therapy|November 27, 2018
Insights into globalization: comparison of patient characteristics and disease progression among geographic regions in a multinational Alzheimer's disease clinical programJeffrey L Cummings, Alireza Atri, Clive Ballard, et al.
Methods in Molecular Biology (Clifton, N.J.)|March 1, 2024
Blood-Based Biomarkers for Early Alzheimer's Disease Diagnosis in Real-World SettingsRobert Perneczky, Niels Hansen, Anna Hofmann, et al.
Alzheimer'S & Dementia (New York, N. Y.)|June 14, 2019
Enrichment factors for clinical trials in mild-to-moderate Alzheimer's diseaseClive Ballard, Alireza Atri, Neli Boneva, et al.
Journal of Applied Gerontology : the Official Journal of the Southern Gerontological Society|December 31, 2014
Out-of-home behavior and cognitive impairment in older adults: findings of the SenTra ProjectMarkus Wettstein, Hans-Werner Wahl, Noam Shoval, et al.
Archives of Gerontology and Geriatrics|September 30, 2023
Effects of an app-based sensorimotor training in promoting neuroplasticity and neuropsychological functioning in frailty: A randomized controlled trialFlorian Beier, Martin Löffler, Frauke Nees, et al.
JAMA|January 11, 2018
Effect of Idalopirdine as Adjunct to Cholinesterase Inhibitors on Change in Cognition in Patients With Alzheimer Disease: Three Randomized Clinical TrialsAlireza Atri, Lutz Frölich, Clive Ballard, et al.
Pageof 20